Antares Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Antares Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ATRS
Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection.
CEORobert F. Apple, CPA
CEORobert F. Apple, CPA
Employees—
Employees—
HeadquartersEwing, New Jersey
HeadquartersEwing, New Jersey
Founded1979
Founded1979
Employees—
Employees—
ATRS Key Statistics
Market cap955.06M
Market cap955.06M
Price-Earnings ratio24.28
Price-Earnings ratio24.28
Dividend yield—
Dividend yield—
Average volume2.37M
Average volume2.37M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.60
52 Week high$5.60
52 Week low$3.11
52 Week low$3.11
Stock Snapshot
As of today, Antares Pharma(ATRS) shares are valued at $5.59. The company's market cap stands at 955.06M, with a P/E ratio of 24.28.
On 2025-12-30, Antares Pharma(ATRS) stock opened at —, reached a high of —, and a low of —.
The Antares Pharma(ATRS)'s current trading volume is 0, compared to an average daily volume of 2.37M.
During the past year, Antares Pharma(ATRS) stock moved between $3.11 at its lowest and $5.60 at its peak.
During the past year, Antares Pharma(ATRS) stock moved between $3.11 at its lowest and $5.60 at its peak.
People also own
Based on the portfolios of people who own ATRS. This list is generated using Robinhood data, and it’s not a recommendation.